SNDL Inc. SNDL
Annual
Quarterly
No annual revenue total was found in SNDL Inc.'s SEC filings.
SNDL Inc. (SNDL) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
263.36M
+0.1% vs prior year
Net cash
—
Operating margin
—
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- SNDL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Alberta, Canada
- Headquarters
- Edmonton
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1766600
- Former names
- Sundial Growers Inc. (until Jul 25, 2022)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- Aurora Cannabis Inc ACB
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 27, 2026 | Oct 27, 2026 |
| 6-K | Current report (foreign issuer) | Oct 27, 2026 | Oct 26, 2026 |
| 6-K | Current report (foreign issuer) | Oct 15, 2026 | Oct 15, 2026 |
| 6-K | Current report (foreign issuer) | Oct 14, 2026 | Oct 14, 2026 |
| 6-K | Current report (foreign issuer) | Oct 6, 2026 | Oct 6, 2026 |
| 6-K | Current report (foreign issuer) | Sep 8, 2026 | Sep 8, 2026 |
Source: SEC EDGAR filings. This is company-reported data, not investment advice.